Brokerages Set Olaplex Holdings, Inc. (NASDAQ:OLPX) Target Price at $1.88

Olaplex Holdings, Inc. (NASDAQ:OLPX) has earned an average rating of “Hold” from the seven research firms that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $1.8871.

Several research firms recently issued reports on OLPX. Zacks Research raised shares of Olaplex from a “strong sell” rating to a “hold” rating in a report on Thursday, February 19th. Wall Street Zen upgraded shares of Olaplex from a “sell” rating to a “hold” rating in a report on Saturday, March 7th. Telsey Advisory Group upped their price target on shares of Olaplex from $2.00 to $2.06 and gave the company a “market perform” rating in a report on Friday. Northland Securities downgraded Olaplex from a “strong-buy” rating to a “hold” rating in a research report on Thursday. Finally, Morgan Stanley set a $1.40 price objective on Olaplex in a research note on Tuesday, March 10th.

Key Stories Impacting Olaplex

Here are the key news stories impacting Olaplex this week:

• Positive Sentiment: Henkel agreed to acquire Olaplex for $2.06 per share (≈$1.4 billion), a ~55% premium to the pre-announcement close; the deal is being pitched as enabling greater investment and distribution for the brand. OLAPLEX to be Acquired by Henkel for $1.4 Billion
• Positive Sentiment: Heavy bullish activity and strong market reaction: premarket headlines and commentary noted a large surge after the announcement, and unusual options activity (large buy of calls) signaled speculative and takeover-arbitrage positioning. Wall Street Breakfast Podcast: Henkel Adds Shine With Olaplex
• Neutral Sentiment: Small analyst adjustments: Telsey Advisory Group raised its price target marginally to $2.06 and kept a “market perform” rating — a modest validation of the deal price but not a strong new bullish signal. Benzinga
• Negative Sentiment: Multiple shareholder-law firms have launched investigations into whether Olaplex shareholders received a fair price or whether there were breaches of fiduciary duty in connection with the sale — this raises litigation risk and could complicate closing/timing. M&A Class Action Firm Announces Investigation Ademi Firm Investigates Fair Price
• Negative Sentiment: Critical analysis and a downgrade: commentary pieces flagged negative implications of the sale for certain stakeholders, and Northland downgraded the stock from “strong-buy” to “hold” — both could reduce enthusiasm among some investors. Henkel Buys Olaplex – Implications Are Negative Zacks (Northland downgrade)

Insider Buying and Selling at Olaplex

In other news, General Counsel John C. Duffy sold 34,962 shares of the company’s stock in a transaction that occurred on Thursday, March 12th. The stock was sold at an average price of $1.26, for a total transaction of $44,052.12. Following the completion of the transaction, the general counsel directly owned 982,855 shares in the company, valued at $1,238,397.30. The trade was a 3.43% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Trisha L. Fox sold 25,421 shares of the stock in a transaction that occurred on Thursday, March 12th. The shares were sold at an average price of $1.26, for a total value of $32,030.46. Following the completion of the sale, the insider directly owned 1,080,363 shares of the company’s stock, valued at $1,361,257.38. This represents a 2.30% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 215,442 shares of company stock valued at $271,457 in the last 90 days. 4.20% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Olaplex

Institutional investors and hedge funds have recently bought and sold shares of the stock. Portolan Capital Management LLC raised its stake in Olaplex by 132.6% during the 3rd quarter. Portolan Capital Management LLC now owns 3,635,124 shares of the company’s stock valued at $4,762,000 after purchasing an additional 2,072,383 shares during the last quarter. Dynamic Technology Lab Private Ltd grew its position in Olaplex by 139.9% in the 2nd quarter. Dynamic Technology Lab Private Ltd now owns 93,933 shares of the company’s stock worth $132,000 after purchasing an additional 54,781 shares during the last quarter. Childress Capital Advisors LLC bought a new position in shares of Olaplex during the 4th quarter worth about $99,000. Savant Capital LLC bought a new position in shares of Olaplex during the 3rd quarter worth about $43,000. Finally, State of Wyoming raised its position in shares of Olaplex by 57.8% during the third quarter. State of Wyoming now owns 344,340 shares of the company’s stock valued at $451,000 after buying an additional 126,099 shares during the last quarter. Institutional investors own 87.37% of the company’s stock.

Olaplex Price Performance

Shares of OLPX stock opened at $2.02 on Friday. The stock’s 50 day simple moving average is $1.51 and its 200 day simple moving average is $1.35. Olaplex has a twelve month low of $0.99 and a twelve month high of $2.02. The company has a debt-to-equity ratio of 0.40, a quick ratio of 4.00 and a current ratio of 4.58. The company has a market capitalization of $1.35 billion, a price-to-earnings ratio of -202.00 and a beta of 2.24.

Olaplex (NASDAQ:OLPX) last announced its earnings results on Thursday, March 5th. The company reported $0.01 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.01. Olaplex had a positive return on equity of 1.07% and a negative net margin of 2.19%.The firm had revenue of $105.12 million during the quarter, compared to analysts’ expectations of $104.21 million. During the same quarter in the prior year, the business earned $0.01 earnings per share. The company’s revenue was up 4.4% on a year-over-year basis. As a group, research analysts predict that Olaplex will post 0.1 EPS for the current year.

Olaplex Company Profile

Olaplex, Inc (NASDAQ: OLPX) is a specialty haircare company known for its patented bond-building technology designed to repair and strengthen hair from within. The company’s core offerings encompass a range of professional salon treatments and at-home maintenance products that target chemical damage, breakage and split ends. Olaplex formulations are built around a proprietary active ingredient that works at the molecular level to rebuild disulfide bonds broken during bleaching, coloring and heat styling processes.

Founded in 2014 and headquartered in Irvine, California, Olaplex initially gained traction among high-end salons before expanding into broader retail channels.